Process for preparing carbamoyloxymethyl triazole cyclohexyl acid compounds

US12459904B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12459904-B2
Application numberUS-202017603659-A
CountryUS
Kind codeB2
Filing dateApr 14, 2020
Priority dateApr 16, 2019
Publication dateNov 4, 2025
Grant dateNov 4, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Improved methods and intermediates thereof for preparing carbamoyloxy methyl triazole cyclohexyl acid compounds are described. These compounds are useful as LPA antagonists. Formula (I).

First claim

Opening claim text (preview).

What is claimed is: 1 . A method of making a compound of Formula (VII), or a stereoisomer or a salt thereof: wherein R a is —N(C 1-4 alkyl) 2 , comprising contacting a compound of Formula (VIII) or a salt thereof: in presence of and a co-catalyst selected from and 4-DMAP, with or without an aqueous base, in Solvent 5 that is a nonpolar solvent, or a solvent mixture thereof; for a time and at a temperature sufficient for reaction completion to produce the compound of Formula (VII) or a stereoisomer or a salt thereof. 2 . The method of claim 1 , for making a compound of Formula (VIIa) or a salt comprising contacting a compound of Formula (VIII) or a salt thereof; in presence of with or without aqueous KOH, in Solvent 5 selected from toluene, CH 2 Cl 2 , trifluorotoluene, 1,2-dichlorobenzene, and a solvent mixture thereof; for a time and at 25 to 35° C. sufficient for reaction completion to produce the compound of Formula (VIIa) or a salt thereof. 3 . The method of claim 2 , for making a compound of Formula (VIIb): comprising contacting a compound of Formula (VIII) or a salt thereof; in presence of with or without aqueous KOH, in toluene; for 24 to 48 hours and at 25 to 35° C. sufficient for reaction completion to produce the compound of Formula (VIIb). 4 . A method of making a compound of Formula (IX), or a stereoisomer or a salt thereof: wherein R a is —N(C 1-4 alkyl) 2 ; comprising contacting a compound of Formula (VII) or a salt thereof: wherein R a is —N(C 1-4 alkyl) 2 ; with a transition-metal catalyst in presence of a diprotic acid in Solvent 6 that is a protic or polar aprotic solvent or a solvent mixture thereof; for a time and at a temperature sufficient for ketone reduction to produce the compound of Formula (IX) or a stereoisomer or a salt thereof. 5 . The method of claim 4 , for making a compound of Formula (IXa) or a salt thereof: comprising contacting a compound of Formula (VIIa) or a salt thereof: with a transition-metal catalyst selected from IrCl 4 , IrCl 4 *hydrate or [Ir(COD)Cl] 2 in presence of phosphorous acid in Solvent 6 selected from IPA, MeOH, EtOH, t-AmOH, H 2 O, NMP, DMF, DMAc, sulfolane, and a solvent mixture thereof; for a time and at 65 to 100° C. sufficient for ketone reduction to produce the compound of Formula (IXa) or a salt thereof. 6 . The method of claim 5 , for making a compound of Formula (IXb): comprising contacting a compound of Formula (VIIb): with IrCl 4 *hydrate or [Ir(COD) Cl] 2 in presence of phosphorous acid in IPA/H 2 O or a solvent mixture thereof; for 24 to 96 hours and at 80 to 85° C. sufficient for ketone reduction to produce the compound of Formula (IXb). 7 . A method of making a compound of Formula (Xa) or a salt thereof: comprising (1) contacting a compound of Formula (IXa) or a salt thereof: with Reagent 3 selected from NaOH, KOH, LiOH, tetraalkylammonium hydroxide, and a mixture thereof, in an aqueous R 7 —OH solution, wherein R 7 are independently C 1-6 alkyl; for up to 48 hours at 80 to 85° C. sufficient for hydrolysis of all three ester moieties to produce the compound of Formula (XI); wherein M is selected from a metal element selected from Li, Na, and K, and tetraalkylammonium; (2) contacting an acid in a protic solvent; and (3) contacting periodic acid in a protic solvent; for up to 48 hours at 20-25° C. sufficient for oxidation to produce the compound of Formula (Xa) or a salt thereof. 8 . The method of claim 7 , for making a compound of Formula (Xa): comprising (1) contacting a compound of Formula (IXb) or a salt thereof: with NaOH in an aqueous IPA solution for at least 12 hours at 80 to 85° C. sufficient to produce the compound of Formula (XIa); (2) contacting aqueous HCl; and (3) contacting periodic acid in an aqueous IPA solution; for up to 48 hours at 20-25° C. sufficient for oxidation to produce the compound of Formula (Xa). 9 . A method of making a compound of Formula (XII), or a stereoisomer or a salt thereof: wherein: R 8 and R 9 are independently N, CH or C(C 1-6 alkyl); R 10 is independently C 1-4 alkyl or halogen; and R 11 is independently Br, Cl or I; comprising contacting a compound of Formula (XIII) or a salt thereof: wherein: R 8 , R 9 , R 10 and R 11 are the same as above in the Formula (XII) and R 1la is halogen; with the compound of Formula (X) or a stereoisomer or a salt thereof: in presence of a metal alkoxide in Solvent 7 that is a polar aprotic or nonpolar solvent, or a solvent mixture thereof; for a time and at a temperature sufficient for reaction completion to produce the compound of Formula (XII) or a stereoisomer or a salt thereof. 10 . The method of claim 9 , for making a compound of Formula (XIIa) or a salt thereof: comprising contacting a compound of Formula (XIIIa) or a salt thereof: with the compound of Formula (Xa) or a salt thereof:

Assignees

Inventors

Classifications

  • directly linked by a ring-member-to-ring-member bond · CPC title

  • with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms · CPC title

  • with halogen-containing compounds which may be formed in situ · CPC title

  • on an oxygen-containing group in organic compounds, e.g. alcohols · CPC title

  • from carboxylic acid esters or lactones · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12459904B2 cover?
Improved methods and intermediates thereof for preparing carbamoyloxy methyl triazole cyclohexyl acid compounds are described. These compounds are useful as LPA antagonists. Formula (I).
Who is the assignee on this patent?
Bristol Myers Squibb Co
What technology area does this patent fall under?
Primary CPC classification C07D249/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).